Radio/telephone ads: established name conjoined with most prominent presentation suffices
Rule
For radio and telephone advertisements, FDA does not intend to object if the established name is disclosed in direct conjunction with the most prominent presentation of the proprietary name (typically its first occurrence).
Check
In radio or telephone ad transcripts/audio, find the most prominent (usually first) presentation of the proprietary name and confirm the established name is disclosed directly with it.
Escalate when
Reviewer is unsure which presentation of the proprietary name in the broadcast is the most prominent one.
Where this comes from
Section II.D.2 · page 8. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.
…lished name be displayed on the screen for the same amount of time as the proprietary name. For superimposed text that typically appears along the bottom of the screen, the established name does not have to be included with the proprietary name. FDA does not intend to object if the established name is not included in the audio portion of audiovisual promotional labeling or in an audiovisual broadcast advertisement. For radio and telephone advertisements, FDA does not intend to object if the established name is disclosed in direct conjunction with the most prominent presentation of the proprietary name. Under most circumstances, this is the first occurrence in the broadcast. Contains Nonbinding Recommendations 3. Electronic and Computer-Based Promotion Promotion in electronic and computer-based media also does not contain text pages like print media. However, promotion in such media often contains information or running text equivalent to many pages of traditional printed text. FDA does n…
- Document
- FDA guidance: Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling (final)
- Version
- as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
- Retrieved
- 2026-09-21 from www.fda.gov
- Fingerprint
- f6f78606542ef91596ef21f6…
FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.